Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceSin categoríaVideos

MPE joins patient organisations call for stronger patient voice in EU health technology assessments

Myeloma Patients Europe has joined 14 other patient organisations members of the European Union Health Technology Assessment (EUHTA) stakeholder network to issue a joint statement on the publication of the first Joint Clinical Assessment (JCA) under the EU Health Technology Assessment Regulation (EUHTAR). The statement was coordinated by the European Patients Forum (EPF) and welcomes…

Read more

Supporting those who care: Introducing the MPE Care Connect Programme

Myeloma Patients Europe (MPE) is proud to announce the launch of the Care Connect Programme, a new initiative dedicated to strengthening support for carers of people living with myeloma and AL amyloidosis across Europe. Carers play a vital role in the lives of patients, providing emotional support, practical assistance, care coordination, and advocacy throughout the myeloma pathway. However, feedback from MPE member organisations has…

Read more

EHA 2026 interviews and highlights

MPE at EHA 2026: Stockholm in review EHA 2026 brought thousands of researchers, clinicians and patient advocates together in Stockholm for four days of cutting-edge science, discussion and connection. For the MPE team, it was a week of in-depth learning and valuable exchanges with stakeholders. What we did Across the congress we attended myeloma scientific…

Read more

European Commission approves subcutaneous isatuximab for the treatment of multiple myeloma

On 8 June 2026, the European Commission approved the subcutaneous (under the skin) formulation of isatuximab (Sarclisa®) for use in all myeloma indications currently approved for the intravenous (IV) formulation of isatuximab. The newly approved subcutaneous formulation can be administered as a subcutaneous injection or using the CirCLIQ® on-body injector. This makes it the first…

Read more

Myeloma EHA 2026 preview

The European Hematology Association (EHA) 2026 Annual Congress, the largest haematology event in Europe, will take place from 11–14 June in Stockholm, Sweden. The congress will bring together experts from across the globe to present the latest advances in haematological diseases, including myeloma and AL amyloidosis. Myeloma Patients Europe (MPE) will be attending EHA to keep…

Read more

World Blood Cancer Day!

To mark World Blood Cancer Day on 28 May, we are highlighting the important work of our Polish member, the Carita Foundation and how they have collaborated with us to raise awareness of important issues with Polish policymakers.  The Carita Foundation has today participated in a meeting of the Parliamentary Working Group on Oncology in the Polish Parliament. This meeting…

Read more
June

July 2026

August
MO
TU
WE
TH
FR
SA
SU
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Events for 1st July
No Events
Events for 2nd July
No Events
Events for 3rd July
No Events
Events for 4th July
No Events
Events for 5th July
No Events
Events for 6th July
No Events
Events for 7th July
No Events
Events for 8th July
No Events
Events for 9th July
No Events
Events for 10th July
No Events
Events for 11th July
No Events
Events for 12th July
No Events
Events for 13th July
No Events
Events for 14th July
No Events
Events for 15th July
No Events
Events for 16th July
No Events
Events for 17th July
No Events
Events for 18th July
No Events
Events for 19th July
No Events
Events for 20th July
No Events
Events for 21st July
No Events
Events for 22nd July
No Events
Events for 23rd July
No Events
Events for 24th July
No Events
Events for 25th July
No Events
Events for 26th July
No Events
Events for 27th July
No Events
Events for 28th July
No Events
Events for 29th July
No Events
Events for 30th July
No Events
Events for 31st July
No Events